loader2
Partner With Us NRI

Ishita Drugs & Industries Ltd share Price Today

Company details

69.60
70.50
46.01
98.37
6M Return 8.47%
1Y Return 29.79%
Mkt Cap.(Cr) 21.06
Volume 208
Div Yield 0.00%
OI
-
OI Chg %
-
Volume 208

Open Free Trading Account Online with ICICIDIRECT

Incur '0' Brokerage upto ₹500

Ishita Drugs & Industries Ltd shares SWOT Analysis

Strengths (3)

  • Company with Low Debt
  • Book Value per share Improving for last 2 years
  • Company with Zero Promoter Pledge

Weakness (6)

  • Inefficient use of capital to generate profits - RoCE declining in the last 2 years
  • Inefficient use of shareholder funds - ROE declining in the last 2 years
  • Inefficient use of assets to generate profits - ROA declining in the last 2 years

Opportunity (0)

Data not found

Threats (0)

Data not found

Resistance and support

R1 70.8
R2 71.1
R3 71.7
Pivot

70.18

S1 69.9
S2 69.3
S3 69.0
EMA SMA
70.1
70.7
71.4
69.7
70.1
70.9
73.2
72.4
Delivery and volume
CLIENT NAME DEAL TYPE ACTION DATE AVG. PRICE QUANTITY EXCHANGE
SHASHANK BHATEJA Bulk Purchase 2024-02-16 83.28 20900 BSE
SHASHANK BHATEJA Bulk Purchase 2024-02-15 79.11 15959 BSE
SHASHANK BHATEJA Bulk Sell 2024-02-15 82.22 15959 BSE
Name Category Shares
SUMIT AGRAWAL PROMOTER 9.77%
ABHA AGRAWAL PROMOTER 7.99%
SHRI JAGDISH AGRAWAL PROMOTER 5.86%
DIVYA SUMIT AGRAWAL PROMOTER 3.48%
KRISHN SUMIT AGRAWAL PROMOTER 3.01%
AGRAWAL JAGDISHPRASAD G PROMOTER 2.84%
VARLIKA SUMIT AGRAWAL PROMOTER 1.34%
ISHITA AGRAWAL PROMOTER 0.84%
UMANG FINANCIAL SERVICES LIMITED PROMOTER 9.94%
ISHITA OVERSEAS PRIVATE LIMITED PROMOTER 4.35%

FINANCIALS

Sales
Operating Profit
Profit after Tax
Equity
Reserves and Surplus
Debt
Sales
Operating Profit
Profit after Tax
PE
Debt/Equity
P BV

Ishita Drugs & Industries Ltd Stocks COMPARISON

Financials( in Cr) Ishita Drugs & Industries Ltd Sun Pharmaceuticals Industries Ltd Cipla Ltd Divis Laboratories Ltd Dr Reddys Laboratories Ltd
Price 70.45 1,506.55 1,409.15 4,016.35 6,252.10
% Change 1 -0.89 0.21 4.49 0.54
Mcap Cr 21.06 361,471.81 113,770.12 106,621.64 104,296.28
Revenue TTM Cr 12.07 43,885.68 15,790.60 7,767.51 24,669.70
Net Profit TTM Cr 0.58 8,560.84 2,513.47 1,823.38 4,507.30
PE TTM 32.29 38.89 28.70 73.72 19.84
1 Year Return 29.79 54.92 54.91 24.48 29.35
ROCE 8.86 16.79 14.76 19.30 25.99
ROE 6.53 16.46 10.66 14.89 21.21
INSIDER & INSTITUTIONAL ACTIVITY

Equity Capital: 9.17 Cr FV: 10.00

Period MF Net Purchase / (sold) FII Net
LAST 1M 20,210.21 -2,261.46
LAST 3M 84,754.55 29,205.23
LAST 6M 143,739.62 78,027.80
LAST 12M 219,616.53 194,212.30

Ishita Drugs & Industries Ltd Information

Stock PE (TTM)
32.29
Promoter Holding
49.42%
Book Value
31.8401
ROCE
8.86%
ROE
6.53%
Description
  • Ishita Drugs & Industries Limited was incorporated in Feb.`92 by Jagdish Agarwal. The Company is engaged in the manufacture of various Activa Pharma Ingredients, drug intermediates, fine chemicals and excipient. It has a state-of-art manufacturing facility, in terms of reaction capabilities, quality control and environmental safety. The plant has been designed and constructed to meet GMP norms. The genesis of the Ishita Group in 1992 was the result of the entrepreneurial spirit of Mr. Jagdish Agrawal, who set up a reactive dye manufacturing unit in Ahmedabad. Buoyed by the growth of its first Venture, the Group made its maiden foray in the pharma sector in 1981 by setting up a small Bulk drugs plant at Surendranagar in Gujarat, to cater to the need of Pharma industry for Quality Products. The Bulk Drugs Industry at that point of time was highly dependent on costly imports and the growth was not achievable. The Company gradually formed a vertically integrated industry chain covering Drug Intermediates, Active Pharma Ingredients (APIs), excipients and finished dosage forms. The Group has 3 manufacturing facilities located in Gujarat, 2 for APIs and drug intermediates (at Ahmedabad and Surendranagar) and 1 for finished pharmaceutical formulations (at Mehsana). Thereafter, the Company set up a project to manufacture bulk drugs at Sanand, in the Ahmedabad district of Gujarat with an installed capacity of 408 tpa. Commercial production commenced in Jan.`95. It established an in-house R&D laboratory which has developed a highly improved process technology for norfloxacin, which was implemented in the plant during Oct.`95. The Company in 2009 undertook a small expansion cum-debottlenecking project; it upgraded many existing equipments.

Registered Address

Survey No 179/1 Taluka Sanand, Village Vasna-Iyava, Ahmedabad, Gujarat, 382170

Email : ishitadrugs:vsnl.net
Website : http://www.ishitadrugs.com
Registrar

Ishita Drugs & Ind. Ltd

AGM Date (Month) : Sep
Face Value Equity Shares : 10
Market Lot Equity Shares : 1
BSE Code : 524400
NSE Code :
Book Closure Date (Month) : Sep
BSE Group : X
ISIN : INE806D01016

FAQ’s on Ishita Drugs & Industries Ltd Shares

You can buy Ishita Drugs & Industries Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Ishita Drugs & Industries Ltd Share.

Company share prices and volatile and keep changing according to the market conditions. As of Apr 26, 2024 04:01 PM the closing price of Ishita Drugs & Industries Ltd was Rs.70.45.

Market capitalization or market cap is determined by multiplying the current market price of a company�s shares with the total number of shares outstanding. As of Apr 26, 2024 04:01 PM, the market cap of Ishita Drugs & Industries Ltd stood at Rs. 21.06.

The latest PE ratio of Ishita Drugs & Industries Ltd as of Apr 26, 2024 04:01 PM is 32.29

The latest PB ratio of Ishita Drugs & Industries Ltd as of Apr 26, 2024 04:01 PM is 0.46

The 52-week high of Ishita Drugs & Industries Ltd share price is Rs. 98.37 while the 52-week low is Rs. 46.01

Download Our

Download App
market app